Equities

PCC Exol SA

PCC Exol SA

Actions
  • Price (EUR)0.585
  • Today's Change-0.002 / -0.34%
  • Shares traded10.00k
  • 1 Year change-11.23%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024 07:15 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PCC Exol SA is a Poland based company active in the chemicals sector. The Company manufactures and sells surfactants (surface active agents) for household chemicals, personal care, textile industry, paper industry and metallurgical industry, among others. It has two manufacturing units, for anionic and nonionic surfactants in Brzeg Dolny, and for ethoxylattion in Plock. It sells its products under the brand names: ABS acid, ABSNa, Sulforokanol, Rosulfany, Sulfobursztyniany, Rokafenol, Rokanol, Rokacet, Rokamid, Rodamin, Rokopol and Rokamina. On May 26, 2014, the Company established new subsidiary, PCC Exol Philippines Inc engaged in the production of semi-products, such as alcohols and fatty acids.

  • Revenue in PLN (TTM)912.83m
  • Net income in PLN34.46m
  • Incorporated2008
  • Employees323.00
  • Location
    PCC Exol SAul. Sienkiewicza 4BRZEG DOLNY 56-120PolandPOL
  • Phone+48 717942127
  • Fax+48 717942550
  • Websitehttps://pcc-exol.eu/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.